Enhanced Replication of Leishmania amazonensis Amastigotes in Gamma Interferon-Stimulated Murine Macrophages: Implications for the Pathogenesis of Cutaneous Leishmaniasis

Infection and Immunity

Volumn 72, Issue 2, 2004, Pages 988-995

  Qi, Hai ^a   Ji, Jiaxiang ^a   Wanasen, Nanchaya ^a   Soong, Lynn ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Medical Research Building 3132 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOLYSIS; DISEASE COURSE; FLUORESCENCE MICROSCOPY; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE; PATHOGENESIS; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

ANIMALS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TEMPERATURE; TH1 CELLS;

EID: 0842283057     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.2.988-995.2004     Document Type: Article

References (53)

1. Afonso, L. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61:2952-2959.
2. Alexander, J., and D. G. Russell. 1992. The interaction of Leishmania species with macrophages. Adv. Parasitol. 31:175-254.
3. Bakhiet, M., T. Olsson, J. Mhlanga, P. Buscher, N. Lycke, P. H. van der Meide, and K. Kristensson. 1996. Human and rodent interferon-γ as a growth factor for Trypanosoma brucei. Eur. J. Immunol. 26:1359-1364.
4. Blackwell, J. M., R. A. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162:324-331.
5. Bogle, R. G., A. R. Baydoun, J. D. Pearson, S. Moncada, and G. E. Mann. 1992. L-Arginine transport is increased in macrophages generating nitric oxide. Biochem. J. 284:15-18.
6. Caivano, M. 1998. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett. 429:249-253.
7. Chakkalath, H. R., and R. G. Titus. 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153:4378-4387.
8. Colmenares, M., S. Kar, K. Goldsmith-Pestana, and D. McMahon-Pratt. 2002. Mechanisms of pathogenesis: differences amongst Leishmania species. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl. 1):S3-S7.
9. Courret, N., C. Frehel, E. Prina, T. Lang, and J. C. Antoine. 2001. Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology 122:263-279.
10. Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762-773.
11. + T cells do not mediate a protective immune response. Immunobiology 195:243-260.
12. Geller, D. A., and T. R. Billiar. 1998. Molecular biology of nitric oxide synthases. Cancer Metast. Rev. 17:7-23.
13. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α. J. Immunol. 145:4290-4297.
14. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:278-283.
15. Hodgkinson, V. H., and L. Soong. 1997. In vitro maintenance of Leishmania amastigotes directly from lesions: advantages and limitations. J. Parasitol. 83:953-956.
16. Holaday, B. J., M. D. Sadick, Z. E. Wang, S. L. Reiner, F. P. Heinzel, T. G. Parslow, and R. M. Locksley. 1991. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 147:1653-1658.
17. Ilg, T. 2000. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J. 19:1953-1962.
18. ω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 193:777-784.
19. Iniesta, V., L. C. Gomez-Nieto, I. Molano, A. Mohedano, J. Carcelen, C. Miron, C. Alonso, and I. Corraliza. 2002. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 24:113-118.
20. Ji, J., J. Sun, and L. Soong. 2003. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 71:4278-4288.
21. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
22. Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Shlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191:1063-1068.
23. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
24. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
25. Love, D. C., M. Mentink Kane, and D. M. Mosser. 1998. Leishmania amazonensis: the phagocytosis of amastigotes by macrophages. Exp. Parasitol. 88:161-171.
26. MacLeod, C. L. 1996. Regulation of cationic amino acid transporter (CAT) gene expression. Biochem. Soc. Trans. 24:846-852.
27. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
28. Mazingue, C., F. Cottrez-Detoeuf, J. Louis, M. Kweider, C. Auriault, and A. Capron. 1989. In vitro and in vivo effects of interleukin 2 on the protozoan parasite Leishmania. Eur. J. Immunol. 19:487-491.
29. Mitchell, G. F. 1983. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major. J. Immunogenet. 10:395-412.
30. Mosser, D. M., and P. J. Edelson. 1987. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 327:329-331.
31. Murray, H. W., and C. F. Nathan. 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189:741-746.
32. Pegg, A. E. 1988. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res. 48:759-774.
33. Pham, T. V., and J. Mauel. 1987. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro. Parasite Immunol. 9:721-736.
34. + T cells in vivo. J. Immunol. 167:4534-4542.
35. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
36. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
37. Sacks, D. L., and P. V. Perkins. 1985. Development of infective stage Leishmania promastigotes within phlebotomine sand flies. Am. J. Trop. Med. Hyg. 34:456-459.
38. Sacks, D. L., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419.
39. Scott, P. 1985. Impaired macrophage leishmanicidal activity at cutaneous temperature. Parasite Immunol. 7:277-288.
40. Scott, P., D. Sacks, and A. Sher. 1983. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis. J. Immunol. 131:966-971.
41. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158:5374-5383.
42. Soong, L., S. M. Duboise, P. Kima, and D. McMahon-Pratt. 1995. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63:3559-3566.
43. Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273.
44. Spath, G. F., L. Epstein, B. Leader, S. M. Singer, H. A. Avila, S. J. Turco, and S. M. Beverley. 2000. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. 97:9258-9263.
45. + T cell response. J. Exp. Med. 181:961-971.
46. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295:338-342.
47. Tapia, F. J., M. Caceres-dittmar, and M. A. Sanchez. 1996. Molecular and immune mechanisms in the pathogenesis of cutaneous leishmaniasis. R. G. Landes Company, Austin, Tex.
48. Vieth, M., A. Will, K. Schroppel, M. Rollinghoff, and A. Gessner. 1994. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 40:403-409.
49. Vouldoukis, I., P. A. Becherel, V. Riveros-Moreno, M. Arock, O. da Silva, P. Debre, D. Mazier, and M. D. Mossalayi. 1997. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 27:860-865.
50. + effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367-1371.
51. Warren, M. K., and S. N. Vogel. 1985. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J. Immunol. 134:982-989.
52. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
53. Yarlett, N., and C. J. Bacchi. 1994. Parasite polyamine metabolism: targets for chemotherapy. Biochem. Soc. Trans. 22:875-879.